• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Miach Orthopaedics secures $40M to support its ACL tears implant

Miach Orthopaedics secures $40M to support its ACL tears implant

January 25, 2023 By Chris Newmarker

Miach Orthopaedics marketing image of its Bear implant to treat a torn ACL
The Bear implant to treat a torn ACL [Image courtesy of Miach Orthopaedics]
Miach Orthopaedics today announced that it’s closed on $40 million in financing to support expanded U.S. commercialization of its Bear implant to treat ACL tears.

The financing includes $30 million in Series B equity from lead investors Sectoral Asset Management and Endeavour Vision. Existing investors — including Amzak Health, Smith+Nephew, DSM Venturing and the NFL Players Association — also joined the funding round.

Additionally, Miach Orthopaedics has signed a $10 million venture debt term sheet with Silicon Valley Bank. The Westborough, Massachusetts–based company plans to close the loan shortly after the closing of the Series B.

Sectoral and Endeavour will have representatives on the Miach board of directors.

“Since launching our Bear implant in fall 2021, we’ve received tremendous interest from both surgeons and patients alike, who understand the benefits of healing a torn ACL rather than replacing it,” Miach Orthopaedics CEO Patrick McBrayer said in a news release.

More about Miach Orthopaedics and its Bear implant

McBrayer added that the company has had more than 500 commercial implants of the Bear implant. “This additional investment will allow us to expand our presence nationwide and bring the benefits of ACL restoration to more patients with ACL tears.”

The FDA granted the Bear implant a De Novo Approval in December 2020. The implant is cylindrical and 45 mm long and 22 mm in diameter. It’s a decellularized, bovine-derived, type I collagen implant that resorbs within eight weeks of implantation.

Bear serves as a bridge to restore the patient’s own ACL, according to the company. Miach Orthopaedics describes Bear as the first medical technology clinically proven to enable the healing of a torn ACL. In contrast, the present standard of care involves a reconstruction that replaces the ACL with a graft.

“The Miach team has made significant progress in U.S. commercialization of the Bear implant over the last year and is well-poised for rapid growth in the ACL repair market,” said Joyce Erony, managing partner of Amzak Health and chair of Miach’s board of directors. “The ability to attract sizeable investment from leading venture capital firms and banks in a difficult fundraising environment is a testament to the Miach team and the potential of the Bear implant to become the standard of care.”

Filed Under: Business/Financial News, Featured, Funding Roundup, News Well, Orthopedics Tagged With: Miach Orthopaedics

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy